Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • CareersExpand
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / Blog - Page 141

Blog

The FDA FDA Issued first Emergency Authorization for sample pooling in diagnostic testing
FDA | Life Science History

The FDA FDA Issued first Emergency Authorization for sample pooling in diagnostic testing

On Jul. 18, 2020, the FDA reissued an emergency use authorization (EUA) to Quest Diagnostics to authorize its…

Read More The FDA FDA Issued first Emergency Authorization for sample pooling in diagnostic testingContinue

FDA authorized Quest Diagnostics COVID-19 diagnostic testing for specimen pooling for emergency use
Life Science History

FDA authorized Quest Diagnostics COVID-19 diagnostic testing for specimen pooling for emergency use

On Jul. 18, 2020, a Health Trendsル study from researchers at Quest Diagnostics and the University of Pittsburgh…

Read More FDA authorized Quest Diagnostics COVID-19 diagnostic testing for specimen pooling for emergency useContinue

Novartis launched first-of-its-kind not-for-profit portfolio of medicines for symptomatic treatment of COVID-19
COVID-19 | Life Science History | Vaccine

Novartis launched first-of-its-kind not-for-profit portfolio of medicines for symptomatic treatment of COVID-19

On Jul. 16, 2020, Novartis announced a new initiative to help patients in low-income and lower-middle-income countries (LIC;…

Read More Novartis launched first-of-its-kind not-for-profit portfolio of medicines for symptomatic treatment of COVID-19Continue

RedHill Biopharma received approval for phase 2/3 COVID-19 study in Russia
Biotechnology | COVID-19 | Therapeutics

RedHill Biopharma received approval for phase 2/3 COVID-19 study in Russia

On Jul. 16, 2020, RedHill Biopharma announced approval from the Ministry of Health of the Russian Federation for…

Read More RedHill Biopharma received approval for phase 2/3 COVID-19 study in RussiaContinue

Dynavax and Mount Sinai announced collaboration to develop a universal influenza vaccine candidate with CpG 1018 adjuvant
Biotechnology | Infectious Disease | Influenza | Vaccine

Dynavax and Mount Sinai announced collaboration to develop a universal influenza vaccine candidate with CpG 1018 adjuvant

On Jul. 16, 2020, Dynavax Technologies and the Icahn School of Medicine at Mount Sinai announced they had…

Read More Dynavax and Mount Sinai announced collaboration to develop a universal influenza vaccine candidate with CpG 1018 adjuvantContinue

Heron Therapeutics announced initiation of phase 2 clinical study of CINVANTIᆴ for treatment of COVID-19
COVID-19 | FDA | Life Science History

Heron Therapeutics announced initiation of phase 2 clinical study of CINVANTIᆴ for treatment of COVID-19

On Jul. 16, 2020, Heron Therapeutics announced initiation of the GUARDS-1 Study, a Phase 2 clinical study evaluating…

Read More Heron Therapeutics announced initiation of phase 2 clinical study of CINVANTIᆴ for treatment of COVID-19Continue

Humanigen expanded partnership with Catalent Biologics to manufacture investigational COVID-19 therapeutic candidate lenzilumab
Life Science History

Humanigen expanded partnership with Catalent Biologics to manufacture investigational COVID-19 therapeutic candidate lenzilumab

On Jul. 16, 2020, Catalent and Humanigen announced the expansion of their relationship, under which Catalent will provide…

Read More Humanigen expanded partnership with Catalent Biologics to manufacture investigational COVID-19 therapeutic candidate lenzilumabContinue

Codex DNA released new synthetic SARS-CoV-2 genome for COVID-19 vaccine and therapeutic research
COVID-19 | Genomics | Life Science History

Codex DNA released new synthetic SARS-CoV-2 genome for COVID-19 vaccine and therapeutic research

On Jul. 16, 2020, Codex DNA announced the release of a new synthetic SARS-CoV-2 genome developed to accelerate…

Read More Codex DNA released new synthetic SARS-CoV-2 genome for COVID-19 vaccine and therapeutic researchContinue

Tufts Center for the Study of Drug Development reported faster new drug approval times were more than offset by longer clinical iimes in US
Life Science History

Tufts Center for the Study of Drug Development reported faster new drug approval times were more than offset by longer clinical iimes in US

On Jul. 16, 2020, the Tufts Center for the Study of Drug Development reported that although regulatory approval…

Read More Tufts Center for the Study of Drug Development reported faster new drug approval times were more than offset by longer clinical iimes in USContinue

Tonix Pharma announced research collaboration to develop precision medicine techniques for COVID-19 vaccines and therapeutics
Biotechnology | COVID-19 | Infectious Disease | Therapeutics | Vaccine

Tonix Pharma announced research collaboration to develop precision medicine techniques for COVID-19 vaccines and therapeutics

On Jul. 16, 2020, Tonix Pharmaceuticals announced it had entered into a research collaboration and option agreement with…

Read More Tonix Pharma announced research collaboration to develop precision medicine techniques for COVID-19 vaccines and therapeuticsContinue

Atossa Therapeutics contracted for clinical study of AT-301 nasal spray for treating COVID-19
COVID-19 | Life Science History

Atossa Therapeutics contracted for clinical study of AT-301 nasal spray for treating COVID-19

On Jul. 16, 2020, Atossa Therapeutics announced that it has contracted with Avance Clinical to conduct a clinical…

Read More Atossa Therapeutics contracted for clinical study of AT-301 nasal spray for treating COVID-19Continue

WHO and UNICEF warn of a decline in vaccinations during COVID-19
COVID-19 | Life Science History | Vaccine | WHO

WHO and UNICEF warn of a decline in vaccinations during COVID-19

On Jul. 14, 2020, the WHO and UNICEF warned of an alarming decline in the number of children…

Read More WHO and UNICEF warn of a decline in vaccinations during COVID-19Continue

More than 150 countries engaged in COVID-19 vaccine global access facility
COVID-19 | Non-Profit Research | Vaccine

More than 150 countries engaged in COVID-19 vaccine global access facility

On Jul. 15, 2020, seventy-five countries submitted expressions of interest to protect their populations and those of other…

Read More More than 150 countries engaged in COVID-19 vaccine global access facilityContinue

HKU mechanical engineering study revealed airborne transmission of COVID-19 opportunistic in nature and poor indoor ventilation plays a role in transmission
CDC | Environmental | Life Science History

HKU mechanical engineering study revealed airborne transmission of COVID-19 opportunistic in nature and poor indoor ventilation plays a role in transmission

On Jul. 15, 2020, in collaboration with the Guangdong CDC, Hunan CDC, Sun Yat-Sen University and Southeast University,…

Read More HKU mechanical engineering study revealed airborne transmission of COVID-19 opportunistic in nature and poor indoor ventilation plays a role in transmissionContinue

BIOFIRE respiratory panel 21 plus with SARS-CoV-2 was CE marked
Biotechnology | COVID-19 | Diagnostics

BIOFIRE respiratory panel 21 plus with SARS-CoV-2 was CE marked

On Jul. 15, 2020, bioMerieux announced that the BIOFIRE Respiratory Panel 2.1 plus (RP2.1plus) was CE marked. The…

Read More BIOFIRE respiratory panel 21 plus with SARS-CoV-2 was CE markedContinue

COVID-19 antibody tests evaluated as diagnostic test in low-resource settings
Biotechnology | COVID-19 | Diagnostics | Non-Profit Research | WHO

COVID-19 antibody tests evaluated as diagnostic test in low-resource settings

On Jul. 15, 2020, scientists at Washington University School of Medicine in St. Louis reported they had joined…

Read More COVID-19 antibody tests evaluated as diagnostic test in low-resource settingsContinue

BD announced purchase agreement with U.S. Dept of HHS to expand access to rapid point-of-care testing for COVID-19
COVID-19 | Diagnostics

BD announced purchase agreement with U.S. Dept of HHS to expand access to rapid point-of-care testing for COVID-19

On Jul. 15, 2020, BD (Becton, Dickinson) announced a commitment from the U.S. Department of Health and Human…

Read More BD announced purchase agreement with U.S. Dept of HHS to expand access to rapid point-of-care testing for COVID-19Continue

BioAegis received approval to proceed with phase 2 trial of its gelsolin COVID-19 treatment
COVID-19 | Life Science History

BioAegis received approval to proceed with phase 2 trial of its gelsolin COVID-19 treatment

On Jul. 15, 2020, BioAegis Therapeutics announced that it received regulatory clearance from The Spanish Agency for Medicines…

Read More BioAegis received approval to proceed with phase 2 trial of its gelsolin COVID-19 treatmentContinue

Tevogen Bio announced steps toward proprietary T Cell therapy for development of bivalent vaccine for COVID-19 and influenza
Biotechnology | COVID-19 | Infectious Disease | Influenza | Vaccine

Tevogen Bio announced steps toward proprietary T Cell therapy for development of bivalent vaccine for COVID-19 and influenza

On Jul. 15, 2020, Tevogen Bio announced its intention to evaluate its proprietary antigen-specific T cell technology as…

Read More Tevogen Bio announced steps toward proprietary T Cell therapy for development of bivalent vaccine for COVID-19 and influenzaContinue

Philanthropic gifts funded COVID-19 pilot research projects at Einstein and Montefiore
COVID-19 | Life Science History

Philanthropic gifts funded COVID-19 pilot research projects at Einstein and Montefiore

On Jul. 15, 2020, four Einstein and Montefiore research teams received pilot funding from Einsteinメs Office of the…

Read More Philanthropic gifts funded COVID-19 pilot research projects at Einstein and MontefioreContinue

AXIM Biotechnologies unveiled first-in-class COVID-19 rapid diagnostic test for neutralizing antibodies
Biotechnology | COVID-19 | Diagnostics

AXIM Biotechnologies unveiled first-in-class COVID-19 rapid diagnostic test for neutralizing antibodies

On Jul. 15, 2020, AXIM Biotechnologies announced the development of NeuCovixTM, a rapid diagnostic test measuring levels of…

Read More AXIM Biotechnologies unveiled first-in-class COVID-19 rapid diagnostic test for neutralizing antibodiesContinue

Cleveland Clinic researchers Identified genetic factors that may Influence COVID-19 susceptibility
Biotechnology | COVID-19 | Diagnostics | Genomics | Non-Profit Research

Cleveland Clinic researchers Identified genetic factors that may Influence COVID-19 susceptibility

On Jul. 15, 2020, A new Cleveland Clinic study identified genetic factors that may influence susceptibility to COVID-19….

Read More Cleveland Clinic researchers Identified genetic factors that may Influence COVID-19 susceptibilityContinue

Atossa Therapeutics announced successful in vitro testing of nasal spray formulation with SARS-CoV-2
Biotechnology | COVID-19 | Therapeutics

Atossa Therapeutics announced successful in vitro testing of nasal spray formulation with SARS-CoV-2

On Jul. 15, 2020, Atossa Therapeutics announced successful results from in vitro testing of AT-301, Atossa’s proprietary COVID-19…

Read More Atossa Therapeutics announced successful in vitro testing of nasal spray formulation with SARS-CoV-2Continue

Placenta lacks major molecules used by SARS-CoV-2 virus to cause infection
Life Science History | NIH

Placenta lacks major molecules used by SARS-CoV-2 virus to cause infection

On Jul. 14, 2020, a study by NIH researchers reported the placental membranes that contain the fetus and…

Read More Placenta lacks major molecules used by SARS-CoV-2 virus to cause infectionContinue

NIH researchers generated complete human X chromosome sequence
Genomics | Life Science History

NIH researchers generated complete human X chromosome sequence

On Jul. 14, 2020, researchers at the National Human Genome Research Institute (NHGRI), part of the NIIH, announced…

Read More NIH researchers generated complete human X chromosome sequenceContinue

Akebia announced initiation of investigator-sponsored study evaluating vadadustat for prevention and treatment of ARDS in patients with COVID-19
Biotechnology | COVID-19 | Therapeutics

Akebia announced initiation of investigator-sponsored study evaluating vadadustat for prevention and treatment of ARDS in patients with COVID-19

On Jul. 14, 2020, Akebia Therapeutics announced the initiation of an investigator-sponsored study evaluating the use of vadadustat,…

Read More Akebia announced initiation of investigator-sponsored study evaluating vadadustat for prevention and treatment of ARDS in patients with COVID-19Continue

Experimental COVID-19 vaccine safe, generated immune response
Biotechnology | COVID-19 | Non-Profit Research | Vaccine

Experimental COVID-19 vaccine safe, generated immune response

On Jul. 14, 2020, an investigational vaccine, mRNA-1273, designed to protect against SARS-CoV-2, the virus that causes coronavirus…

Read More Experimental COVID-19 vaccine safe, generated immune responseContinue

CDC called on Americans to wear masks to prevent COVID-19 spread
CDC | COVID-19 | Life Science History

CDC called on Americans to wear masks to prevent COVID-19 spread

On Jul. 14, 2020, in an editorial published in the Journal of the American Medical Association (JAMA), the…

Read More CDC called on Americans to wear masks to prevent COVID-19 spreadContinue

CDC called on Americans to wear masks to prevent COVID-19 spread
CDC | COVID-19 | Life Science History

CDC called on Americans to wear masks to prevent COVID-19 spread

On Jul. 14, 2020, in an editorial published in the Journal of the American Medical Association (JAMA), the…

Read More CDC called on Americans to wear masks to prevent COVID-19 spreadContinue

HKUMed researchers mined immunogenic information from SARS-CoV-2 for rational design of vaccine against SARS-CoV-2
COVID-19 | Life Science History | Vaccine

HKUMed researchers mined immunogenic information from SARS-CoV-2 for rational design of vaccine against SARS-CoV-2

On Jul. 14, 2020, researchers at the The University of Hong Kong (HKUMed) collaborated with researchers at the…

Read More HKUMed researchers mined immunogenic information from SARS-CoV-2 for rational design of vaccine against SARS-CoV-2Continue

Page navigation

Previous PagePrevious 1 … 139 140 141 142 143 … 348 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemical
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Life Science Banner Advertising
  • Advertise Your Life Science Jobs

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • Careers
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search